Fosun Pharma says will buy Israel's Alma Lasers Ltd for $240 million
HONG KONG, April 28
HONG KONG, April 28 (Reuters) - Shanghai Fosun Pharma (Group) Ltd said on Sunday it would spend up to $240 million to acquire up to 96.6 percent of Israel-based Alma Lasers Ltd, a manufacturer of lasers used in cosmetic surgery.
It is the first major buyout deal by Fosun Pharma since it listed on the Hong Kong Stock Exchange last October.
Fosun Pharma, a subsidiary of China's Fosun International Limited, said it would make the investment together with Pramerica-Fosun China Opportunity Fund, a US-dollar denominated investment fund owned by Fosun Group.
- Israel pummels Gaza; Kerry steps up diplomatic push |
- With sales sputtering, Apple's iPad looks to IBM alliance
- Ukraine war crimes trials a step closer after Red Cross assessment
- Rebels likely downed Malaysian jet 'by mistake': U.S. officials
- Five held in China food scandal probe, including head of Shanghai Husi Food